United States

Fresenius Medical Care AG & Co KGaA (FMS.N)

FMS.N on New York Stock Exchange

22 Mar 2017
Change (% chg)

$0.26 (+0.63%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for FMS.N


Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the... (more)


Beta: 0.56
Market Cap(Mil.): $25,308.58
Shares Outstanding(Mil.): 614.48
Dividend: 0.45
Yield (%): 1.10


  FMS.N Industry Sector
P/E (TTM): 20.30 32.41 30.07
EPS (TTM): 2.03 -- --
ROI: 7.83 5.62 13.05
ROE: 12.01 8.85 14.20

UPDATE 1-Fresenius aims for double-digit growth through 2020

* FMC sees slowing profit growth in 2017 (Adds details, Fresenius results)

Feb 22 2017

FMC forecasts slowing net income growth for 2017

FRANKFURT, Feb 22 The world's largest kidney dialysis provider Fresenius Medical Care (FMC) said it expected its net income growth to slow to between 7 and 9 percent this year, after a 21 percent jump last year.

Feb 22 2017

UPDATE 1-FMC takes control of Australian outpatient treatment chain

* FMC diversifying into therapeutic areas beyond kidney (Adds strategic rationale, percentage of stake taken, report on price)

Feb 03 2017

FMC buys majority stake in Australian hospital group Cura

FRANKFURT, Feb 3 Germany dialysis specialist Fresenius Medical Care said it was buying a majority stake in Cura Group, a leading operator of high-quality day hospitals in Australia.

Feb 03 2017

BRIEF-Fresenius Medical Care acquires majority stake in Cura Group

* Is acquiring a majority stake in Cura Group and scales up in Australia

Feb 03 2017

Dialysis provider FMC settles with U.S. veterans department

FRANKFURT, Jan 31 Dialysis provider Fresenius Medical Care (FMC) settled a dispute with the United States Departments of Veterans Affairs and Justice over outstanding payments and expects to book a net income gain of 45 to 50 million euros ($48.2-$53.5 million) as a result.

Jan 31 2017

BRIEF-Fresenius Medical Care reaches agreement on outstanding payments

* Reached amicable agreement with U.S. Departments of veterans affairs and justice resolving reimbursement for services provided to veterans

Jan 31 2017

BRIEF-Fresenius Medical Care: U.S. court grants temporary restraining order

* U.S. court has granted a temporary restraining order (TRO) requested by dialysis patients citizens, Fresenius Medical Care, Davita, and US Renal, with the support of the American kidney foundation

Jan 13 2017

BRIEF-Cytosorbents and Fresenius Medical Care agree to broaden terms of existing partnership

* Fresenius Medical Care, Cytosorbents agreed to broaden terms of existing partnership,to add expansive co-marketing deal for Cytosorb

Jan 09 2017

Fresenius Medical, DaVita subpoenaed over premium assistance

BERLIN/NEW YORK German's Fresenius Medical Care and U.S. rival DaVita Inc said they had both received subpoenas from federal prosecutors investigating their ties with a charity that helps patients pay for kidney dialysis.

Jan 07 2017

More From Around the Web

Earnings vs. Estimates